格隆汇1月25日丨保集健康(01246.HK)公布截至2025年3月31日止年度业绩，收益7692万港元，同比减少 73.03%；公司拥有人应占亏损约8.3亿港元，同比增长约6倍；每股亏损61.12港仙。 集团于2025财年的整体表现欠佳，乃由于受到放款人将物业拍卖而非进行开发所带来的不利影响，集团 于2025财年取得来自综合产业园项目的发展中物业的可变现净值亏损拨备约2.995亿港元(2024财年： 3660万港元)及于2025财年取得投资物业公允值亏损约4.492亿港元(2024财年：1880万港元)。 ...

Core Viewpoint - The company reported a significant increase in revenue but also experienced a rise in losses, indicating challenges in profitability despite sales growth [1] Financial Performance - Revenue for the six months ending September 30, 2025, was HKD 51.738 million, representing an approximate 59% year-on-year increase [1] - The loss attributable to shareholders was HKD 35.509 million, which is a 31.65% increase compared to the previous year [1] - The loss per share was HKD 0.0261 [1] Revenue Drivers - The revenue growth was primarily driven by increased sales in the building materials and health, medical, and leisure segments [1] - The net impact of reduced property deliveries from the Yangzhong project for the six months ending September 30, 2024, also contributed to the revenue increase [1] Cost Factors - The increase in net losses was mainly due to a decrease in gross profit and an increase in financial costs [1]

Core Viewpoint - The company reported a significant increase in revenue but also faced a larger net loss due to decreased gross profit and increased financial costs [1] Financial Performance - Revenue for the six months ending September 30, 2025, was HKD 51.738 million, representing an approximate 59% year-on-year growth [1] - The loss attributable to owners was HKD 35.509 million, which is a 31.65% increase compared to the previous year [1] - The loss per share was HKD 0.0261 [1] Revenue Drivers - The revenue growth was primarily driven by increased sales in the building materials and health, medical, and leisure segments [1] - The net impact of reduced property deliveries under the Yangzhong project for the six months ending September 30, 2024, also contributed to the revenue changes [1] Cost Factors - The increase in net loss was mainly due to a decrease in gross profit and an increase in financial costs [1]

Group 1 - The core viewpoint of the article is that 保集健康 (Company) reported a significant increase in revenue but also a notable increase in losses for the six months ending September 30, 2025 [1] Group 2 - The company reported revenue of HKD 51.738 million, representing a year-on-year growth of approximately 59% [1] - The loss attributable to owners increased to HKD 35.509 million, a year-on-year increase of 31.65% [1] - The loss per share was reported at HKD 0.0261 [1] Group 3 - Revenue growth was primarily driven by increased sales in the building materials and health care and leisure segments [1] - The net impact of reduced property deliveries from the Yangzhong project for the six months ending September 30, 2024, also contributed to revenue growth [1] - The increase in net loss was mainly due to a decrease in gross profit and an increase in financial costs [1]

公告称，集团于2025财年的整体表现欠佳，乃由于受到放款人将物业拍卖而非进行开发所带来的不利影 响，集团于2025财年取得来自综合产业园项目的发展中物业的可变现净值亏损拨备约2.995亿港元(2024 财年：3660万港元)及于2025财年取得投资物业公允值亏损约4.492亿港元(2024财年：1880万港元)。 保集健康(01246)公布截至2025年3月31日止年度业绩，收益7692万港元，同比减少73.03%;公司拥有人 应占亏损约8.3亿港元，同比增长约6倍;每股亏损61.12港仙。 ...

公告称，收益减少主要由于扬中项目下交付的物业减少的净影响。亏损净额增加主要是由于借款增加令 财务成本增加、财务担保合约的预期信贷亏损以及毛利减少，惟部分被行政及其他开支减少所抵销。 智通财经APP讯，保集健康(01246)公布截至2024年9月30日止6个月中期业绩，实现收益约3253.3万港 元，同比减少88.16%;公司拥有人应占亏损2697.2万港元，同比扩大约2.38倍;每股亏损1.99港仙。 ...

收益减少主要由于扬中项目下交付的物业减少的净影响。亏损净额增加主要是由于借款增加令财务成本 增加、财务担保合约的预期信贷亏损以及毛利减少，惟部分被行政及其他开支减少所抵销。 格隆汇1月25日丨保集健康(01246.HK)公布截至2024年9月30日止6个月中期业绩，实现收益约3253.3万 港元，同比减少88.16%；公司拥有人应占亏损2697.2万港元，同比扩大约2.38倍；每股亏损1.99港仙。 ...

公告称，收益减少主要由于扬中项目下交付的物业减少的净影响。亏损净额增加主要是由于借款增加令 财务成本增加、财务担保合约的预期信贷亏损以及毛利减少，惟部分被行政及其他开支减少所抵销。 保集健康(01246)公布截至2024年9月30日止6个月中期业绩，实现收益约3253.3万港元，同比减少 88.16%;公司拥有人应占亏损2697.2万港元，同比扩大约2.38倍;每股亏损1.99港仙。 ...

保集健康控股有限公司 （於開曼群島註冊成立之有限公司） 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任 何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Boill Healthcare Holdings Limited （股份代號：1246） 茲提述本公司(1)於二零二四年六月二十八日二十二時五十三分及二十二時五十七 分刊發的公告；(2)二零二四年業績公告及(3)聯交所日期為二零二五年二月十三 日有關第二項進一步復牌指引（「第二項進一步復牌指引」）的公告（統稱「過往公告」）。 (I) 獨立法證調查的主要結果 背景 誠如於二零二四年業績公告所披露，於二零二四財年，本公司確認以下預期 信貸虧損：(i)約人民幣41.5百萬元，涉及上海保賢及若干擔保人為上海顧臻（於 關鍵時間由裘東方先生所控制的公司）所借二零二三年SHG貸款提供的二零 二三年未經授權擔保；及(ii)約人民幣123.5百萬元，涉及非控股權益貸款。 此外，本公司於二零二四年三月二十七日以零代價向一名獨立第三方出售於 金盛隆集團的100%股權， ...

致：香港交易及結算所有限公司 公司名稱: 保集健康控股有限公司 呈交日期: 2026年1月20日 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01246 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 480,000,000 | HKD | | 0.25 HKD | | | 120,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | | 本月底結存 | | | 480,000,000 | HKD | | 0.25 HKD | | | 120,000,000 | 本月底法定/註冊股本 ...